BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

LD-2 disclosure · 2nd Quarter - Report

MARATHON PHARMACEUTICALS, LLC

via UPSTREAM CONSULTING

2nd Quarter (Apr 1 - June 30) · 2014Posted Jul 20, 2014Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: MARATHON PHARMACEUTICALS, LLC
Description: Manufacturing Pharmaceuticals
Location: Illinois · United States of America

Registrant

Firm: UPSTREAM CONSULTING
Description: Government Relations
Location: Catharpin, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
Medicare reimbursement
Lobbyistsmr MICHAEL J EGING · JOHN M. HADDOW
Covered position (mr MICHAEL J EGING): Principal
Covered position (JOHN M. HADDOW): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MARATHON PHARMACEUTICALS, LLC — Lobbying — Receipts Report